DGX

QUEST DIAGNOSTICS INC

SEC CIK 1022079
$195.00 −4.6% · 90 days
90-day buys
$0
0 open-market
90-day sells
$3.57M
2 open-market
Net insider flow
−$3.57M
Net selling
Filings shown
183
Most recent
Advertisement

At a glance

Over the last 90 days, insiders at DGX have sold a net $3.57M of stock (0 open-market buys vs 2 sells).

Largest recent trade: Rusckowski Stephen H sold $35.04M of DGX, trimming their stake 55%.

Most active filer: Doherty Catherine T., with 44 transactions among the recent filings shown.

Insider transaction history

Form 4 filings for DGX, newest first
View on SEC EDGAR ↗
DGX
Sell Doherty Catherine T. · SVP, Regional Businesses · Open-market sale · filed Mar 6, 2023 ΔOwn −1.0%

Doherty Catherine T. sold $100.8K of DGX, trimming their stake 1%.

−$100.8K
717 sh @ $141
DGX
Sell PREVOZNIK MICHAEL E · SVP & General Counsel · Open-market sale · filed Mar 3, 2023 ΔOwn −1.5%

Prevoznik Michael E sold $82.2K of DGX, trimming their stake 2%.

−$82.2K
593 sh @ $139
DGX
Sell PREVOZNIK MICHAEL E · SVP & General Counsel · Open-market sale · filed Feb 27, 2023 ΔOwn −3.5%

Prevoznik Michael E sold $200.1K of DGX, trimming their stake 3%.

−$200.1K
1,415 sh @ $141
DGX
Sell Doherty Catherine T. · SVP, Regional Businesses · Open-market sale · filed Feb 27, 2023 ΔOwn −2.4%

Doherty Catherine T. sold $239K of DGX, trimming their stake 2%.

−$239K
1,690 sh @ $141
DGX
Sell Doherty Catherine T. · SVP, Regional Businesses · Open-market sale · filed Nov 29, 2022 ΔOwn −16%

Doherty Catherine T. sold $2.58M of DGX, trimming their stake 16%.

−$2.58M
17,358 sh @ $149
Advertisement
DGX
Sell Doherty Catherine T. · SVP, Regional Businesses · Open-market sale · filed Nov 29, 2022 ΔOwn −26%

Doherty Catherine T. sold $3.5M of DGX, trimming their stake 26%.

−$3.5M
23,407 sh @ $149
DGX
Sell RUSCKOWSKI STEPHEN H · Director, Chairman, CEO and President · Open-market sale · filed May 26, 2022 ΔOwn −2.0%

Rusckowski Stephen H sold $959K of DGX, trimming their stake 2%.

−$959K
6,821 sh @ $141
DGX
Sell RUSCKOWSKI STEPHEN H · Director, Chairman, CEO and President · Open-market sale · filed May 26, 2022 ΔOwn −0.8%

Rusckowski Stephen H sold $362.6K of DGX, trimming their stake 1%.

−$362.6K
2,565 sh @ $141
DGX
Sell RUSCKOWSKI STEPHEN H · Director, Chairman, CEO and President · Open-market sale · filed May 26, 2022 ΔOwn −0.2%

Rusckowski Stephen H sold $92.5K of DGX.

−$92.5K
651 sh @ $142
DGX
Sell RUSCKOWSKI STEPHEN H · Director, Chairman, CEO and President · Open-market sale · filed May 26, 2022 ΔOwn −2.8%

Rusckowski Stephen H sold $1.38M of DGX, trimming their stake 3%.

−$1.38M
9,823 sh @ $141
DGX
Sell RUSCKOWSKI STEPHEN H · Director, Chairman, CEO and President · Open-market sale · filed May 26, 2022 ΔOwn −1.2%

Rusckowski Stephen H sold $583.9K of DGX, trimming their stake 1%.

−$583.9K
4,131 sh @ $141
DGX
Sell RUSCKOWSKI STEPHEN H · Director, Chairman, CEO and President · Open-market sale · filed May 26, 2022 ΔOwn −0.3%

Rusckowski Stephen H sold $127.9K of DGX.

−$127.9K
900 sh @ $142
DGX
Sell RUSCKOWSKI STEPHEN H · Director, Chairman, CEO and President · Open-market sale · filed May 25, 2022 ΔOwn −27%

Rusckowski Stephen H sold $17.67M of DGX, trimming their stake 27%.

−$17.67M
126,126 sh @ $140
DGX
Sell RUSCKOWSKI STEPHEN H · Director, Chairman, CEO and President · Open-market sale · filed May 25, 2022 ΔOwn −32%

Rusckowski Stephen H sold $21.9M of DGX, trimming their stake 32%.

−$21.9M
156,282 sh @ $140
DGX
Sell RUSCKOWSKI STEPHEN H · Director, Chairman, CEO and President · Open-market sale · filed May 25, 2022 ΔOwn −9.2%

Rusckowski Stephen H sold $4.75M of DGX, trimming their stake 9%.

−$4.75M
33,898 sh @ $140
DGX
Sell RUSCKOWSKI STEPHEN H · Director, Chairman, CEO and President · Open-market sale · filed May 25, 2022 ΔOwn −0.2%

Rusckowski Stephen H sold $113.2K of DGX.

−$113.2K
800 sh @ $142
DGX
Sell RUSCKOWSKI STEPHEN H · Director, Chairman, CEO and President · Open-market sale · filed May 25, 2022 ΔOwn −0.1%

Rusckowski Stephen H sold $28.5K of DGX.

−$28.5K
200 sh @ $142
DGX
Sell RUSCKOWSKI STEPHEN H · Director, Chairman, CEO and President · Open-market sale · filed May 25, 2022 ΔOwn −11%

Rusckowski Stephen H sold $5.78M of DGX, trimming their stake 11%.

−$5.78M
41,268 sh @ $140
DGX
Sell RUSCKOWSKI STEPHEN H · Director, Chairman, CEO and President · Open-market sale · filed May 25, 2022 ΔOwn −0.3%

Rusckowski Stephen H sold $141.5K of DGX.

−$141.5K
1,000 sh @ $142
DGX
Sell RUSCKOWSKI STEPHEN H · Director, Chairman, CEO and President · Open-market sale · filed May 25, 2022 ΔOwn −0.1%

Rusckowski Stephen H sold $42.7K of DGX.

−$42.7K
300 sh @ $142
DGX
Sell PREVOZNIK MICHAEL E · SVP & General Counsel · Open-market sale · filed May 19, 2022 ΔOwn −56%

Prevoznik Michael E sold $7.08M of DGX, trimming their stake 56%.

−$7.08M
50,604 sh @ $140
DGX
Sell PREVOZNIK MICHAEL E · SVP & General Counsel · Open-market sale · filed Mar 9, 2022 ΔOwn −14%

Prevoznik Michael E sold $842.1K of DGX, trimming their stake 14%.

−$842.1K
6,228 sh @ $135
DGX
Sell Doherty Catherine T. · SVP, Group Exec. Clin. Fran. · Open-market sale · filed Mar 9, 2022 ΔOwn −9.4%

Doherty Catherine T. sold $950.8K of DGX, trimming their stake 9%.

−$950.8K
7,032 sh @ $135
DGX
Sell PREVOZNIK MICHAEL E · SVP & General Counsel · Open-market sale · filed Mar 2, 2022 ΔOwn −1.7%

Prevoznik Michael E sold $85.9K of DGX, trimming their stake 2%.

−$85.9K
661 sh @ $130
DGX
Sell Doherty Catherine T. · SVP, Group Exec. Clin. Fran. · Open-market sale · filed Feb 28, 2022 ΔOwn −4.1%

Doherty Catherine T. sold $347.2K of DGX, trimming their stake 4%.

−$347.2K
2,750 sh @ $126
DGX
Sell PREVOZNIK MICHAEL E · SVP & General Counsel · Open-market sale · filed Feb 28, 2022 ΔOwn −4.3%

Prevoznik Michael E sold $210.7K of DGX, trimming their stake 4%.

−$210.7K
1,669 sh @ $126
DGX
Sell Doherty Catherine T. · SVP, Group Exec. Clin. Fran. · Open-market sale · filed Dec 1, 2021 ΔOwn −3.1%

Doherty Catherine T. sold $503.1K of DGX, trimming their stake 3%.

−$503.1K
3,250 sh @ $155
DGX
Sell Doherty Catherine T. · SVP, Group Exec. Clin. Fran. · Open-market sale · filed Dec 1, 2021 ΔOwn −3.4%

Doherty Catherine T. sold $550.2K of DGX, trimming their stake 3%.

−$550.2K
3,532 sh @ $156
DGX
Sell Doherty Catherine T. · SVP, Group Exec. Clin. Fran. · Open-market sale · filed Dec 1, 2021 ΔOwn −16%

Doherty Catherine T. sold $2.5M of DGX, trimming their stake 16%.

−$2.5M
15,908 sh @ $157
Advertisement

About DGX insider activity

This page tracks every recent Form 4 filed for QUEST DIAGNOSTICS INC with the U.S. Securities and Exchange Commission. Form 4 is the disclosure that company insiders — officers, directors, and holders of more than 10% of the stock — must file within two business days of buying or selling shares.

The summary above nets open-market purchases against open-market sales over the trailing 90 days. Open-market trades (codes P and S) tend to carry the most signal because they reflect a deliberate choice to put money in or take it out, as opposed to routine grants, option exercises, or tax-withholding events. Use the badges on each row to tell them apart, and always confirm details against the original filing before drawing conclusions.

Frequently asked questions

How often is DGX insider data updated?

Continuously. We read from SEC EDGAR, so new Form 4 filings for QUEST DIAGNOSTICS INC usually appear here within minutes of being accepted by the SEC.

What does "net insider flow" mean?

It is the total dollar value of open-market insider purchases minus open-market sales over the last 90 days. A positive number (green) means insiders bought more than they sold; a negative number (red) means the reverse.

Why do some rows show grants or option exercises instead of buys?

Insiders receive stock through compensation as well as buying it outright. Form 4 captures all of these. We label each transaction by its SEC code so you can focus on open-market activity if you prefer.

Is this investment advice?

No. InsiderSource presents public filing data for informational purposes only. Insider activity is one of many factors to consider and is never a recommendation to buy or sell.